Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 21 Lung Neoplasms 10 Stomach Neoplasms 9 Neoplasm Metastasis 8 Breast Neoplasms 8 Esophageal Neoplasms 7 Colorectal Neoplasms 6 Small Cell Lung Carcinoma 5 Pancreatic Neoplasms 5 Leukemia, Myeloid, Acute 5 Triple Negative Breast Neoplasms 4 Ovarian Neoplasms 4 Nasopharyngeal Carcinoma 4 Esophageal Squamous Cell Carcinoma 4 Adenocarcinoma Of Esophagus 4 Uterine Cervical Neoplasms 3 Head and Neck Neoplasms 3 Fallopian Tube Neoplasms 3 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 Mouth Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Glioma 2 Endometrial Neoplasms 2 Carcinoma, Squamous Cell 2 Carcinoma, Ovarian Epithelial 2 Anus Neoplasms 2 Anatomic Stage II Breast Cancer AJCC v8 2

Interventions

Cyclophosphamide 15 venetoclax 11 fludarabine 10 Cytarabine 10 Mycophenolic Acid 6 Azacitidine 6 fludarabine phosphate 5 Daunorubicin 5 Busulfan 5 ruxolitinib 4 ponatinib 4 blinatumomab 4 Whole-Body Irradiation 4 Vincristine 4 Tacrolimus 4 Rituximab 4 Methotrexate 4 Dexamethasone 4 asciminib 3 Mercaptopurine 3 Inotuzumab Ozogamicin 3 Granulocyte Colony-Stimulating Factor 3 Cyclosporine 3 revumenib 2 quizartinib 2 pegaspargase 2 nilotinib 2 ibrutinib 2 Thioguanine 2 Prednisone 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Leukemia × Drug Therapy × 90 days × Clear all

NCT06578247 2026-04-30

QuANTUM-WILD

Daiichi Sankyo

Phase 3 Recruiting

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡